Valeant gives Pershing Square a seat on its board

(Reuters) - Valeant Pharmaceuticals International Inc (NYSE: VRX) (NYSE: VRX), under scrutiny for its accounting and business practices, said it had given shareholder Pershing Square Capital Management a seat on its board and added two additional directors.

Stephen Fraidin, a veteran Wall Street lawyer who is vice chairman at William Ackman's Pershing Square, has joined the board, along with Fred Eshelman and Thomas Ross, Valeant said.

Anders Lonner has stepped down as a director, the company said on Wednesday.

(Reporting by Ankur Banerjee in Bengaluru; Editing by Ted Kerr)

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Three killed, 15 injured in Moscow explosion, TASS says
• Migrants say hunger and hostility drove them back from Spain's Ceuta to Morocco
• Spain installs floating barrier in Ceuta after deadly migrant rush